Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $92 from $94 and keeps an Outperform rating on the shares. The firm updated estimates in the life insurance group post the Q2 reports.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET: